We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Handheld Microscopic Brain Imaging Device

By Biotechdaily staff writers
Posted on 09 Sep 2005
Scientists have devised a promising, minimally invasive optical method that can capture micron-scale images from deep in the brains of living organisms. More...
The technique, called two-photon microendoscopy, combines two powerful optical and mechanical methods into one device that fits in the palm of the hand.

A study of the technique, performed by researchers at Stanford University (CA, USA), was published in the September 1, 2005, issue of the journal Optics Letters. Researchers are developing ways to image individual cells inside living organisms to provide insights into how cellular behavior affects the characteristics of organisms as a whole. For instance, the nerve cells of the hippocampus area of the brain affect critical mental processes such as learning and memory.

Instead of the traditional one higher-energy photon method currently used, scientists hit the molecule with two photons of lower energy. Their combined energies total the energy needed to excite the fluorescent-dye molecules used to mark the tissue. The method eliminates the background haze and decreases scattering, because molecules outside the area of interest are much less likely to absorb a pair of photons simultaneously and fluoresce in response.

Whereas two-photon microscopy provides an alternative to conventional one-photon fluorescence microscopy, it still only penetrates brain tissue down to approximately 500-600 microns--scarcely grazing the surface. To get a look at the deep structures, the Stanford scientists utilized two microendoscopy tools, very small, minimally invasive optical probes that could be inserted deep into living brain tissue. To produce one group of images, they positioned the microendoscope into the hippocampus, approximately one millimeter below the brain surface of the mouse, to visualize this area of the brain. The two-photon imaging provided an additional 80 microns of depth, underneath the hippocampal surface.

When integrated with two-photon fluorescence, the result is a system that brings the power of an advanced imaging technique to the deep tissues of the brain. The researchers have used their two-photon microendoscopy method to collect the detailed images of the blood vessels in the hippocampus sections of the brains of live mice. The mice were injected with a fluorescein dye, a U.S Food and Drug Administration- (FDA)-approved contrast agent that is most frequently used for retinal exams in humans. The fluorescein labeled the blood plasma so the vessels in the brain could be clearly seen.




Related Links:
Stanford University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.